Literature DB >> 10495434

Anti-neuroblastoma antibody chCE7 binds to an isoform of L1-CAM present in renal carcinoma cells.

M L Meli1, F Carrel, R Waibel, H Amstutz, N Crompton, R Jaussi, H Moch, P A Schubiger, I Novak-Hofer.   

Abstract

Immunoprecipitation after cell surface labeling of human neuroblastoma cells showed that the anti-neuroblastoma monoclonal antibody (mAb) chCE7 binds to a 200,000 M(r) cell surface protein. The protein was partially purified by immuno-affinity chromatography from a human renal carcinoma and a human neuroblastoma cell line, which both showed high levels of binding of MAb chCE7. NH(2)-terminal sequences of 18 and 15 amino acid residues were determined. Both sequences isolated from the renal carcinoma and the neuroblastoma cells showed strong homology to human cell adhesion molecule L1 (L1-CAM), and both were characterized by the NH(2)-terminal deletion of 5 amino acids, comprising exon 2 of L1-CAM. Reverse trancription-polymerase chain reaction (RT-PCR) analysis of the regions spanning exon 2 and exon 27 of L1-CAM indicated that in neuroblastoma cells both transcripts for the full-length and exon-deleted forms are present, whereas in the renal carcinoma cell lines only the exon-deleted L1-CAM isoform were detected. Western blot analysis showed that 6 of 7 tested renal carcinoma cell lines and 5 of 15 renal carcinoma tissues expressed L1-CAM. In normal adult kidney tissue, very low levels of protein expression were found. Northern blot analysis confirmed that in renal carcinoma and neuroblastoma cell lines L1-CAM mRNA levels are correlated with protein expression. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10495434     DOI: 10.1002/(sici)1097-0215(19991029)83:3<401::aid-ijc17>3.0.co;2-a

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.

Authors:  Ru Chen; Sheng Pan; Kelly Cooke; Kara White Moyes; Mary P Bronner; David R Goodlett; Ruedi Aebersold; Teresa A Brentnall
Journal:  Pancreas       Date:  2007-01       Impact factor: 3.327

Review 2.  L1CAM malfunction in the nervous system and human carcinomas.

Authors:  Michael K E Schäfer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2010-03-17       Impact factor: 9.261

3.  L1CAM is involved in lymph node metastasis via ERK1/2 signaling in colorectal cancer.

Authors:  Qing-Xia Fang; Xiao-Chun Zheng; Hua-Jun Zhao
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 4.  Driving CAR T-cells forward.

Authors:  Hollie J Jackson; Sarwish Rafiq; Renier J Brentjens
Journal:  Nat Rev Clin Oncol       Date:  2016-03-22       Impact factor: 66.675

5.  L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.

Authors:  Verena Tischler; Marco Pfeifer; Silke Hausladen; Uwe Schirmer; Anne-Katrine Bonde; Glen Kristiansen; Martin L Sos; Walter Weder; Holger Moch; Peter Altevogt; Alex Soltermann
Journal:  Mol Cancer       Date:  2011-10-10       Impact factor: 27.401

Review 6.  Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.

Authors:  Nan Li; Madeline R Spetz; Dan Li; Mitchell Ho
Journal:  Pharmacol Ther       Date:  2021-05-14       Impact factor: 13.400

7.  L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.

Authors:  Dong Hyun Jo; Kyungmin Lee; Jin Hyoung Kim; Hyoung Oh Jun; Younghoon Kim; Young-Lai Cho; Young Suk Yu; Jeong-Ki Min; Jeong Hun Kim
Journal:  Oncotarget       Date:  2017-02-28

8.  Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule.

Authors:  Muhua Yang; Shalini Adla; Murali K Temburni; Vivek P Patel; Errin L Lagow; Owen A Brady; Jing Tian; Magdy I Boulos; Deni S Galileo
Journal:  Cancer Cell Int       Date:  2009-10-29       Impact factor: 5.722

9.  The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells.

Authors:  Luigi Maddaluno; Sue Ellen Verbrugge; Chiara Martinoli; Gianluca Matteoli; Andrea Chiavelli; Yiping Zeng; Elizabeth D Williams; Maria Rescigno; Ugo Cavallaro
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

Review 10.  CAR T Cell Therapy for Neuroblastoma.

Authors:  Rebecca M Richards; Elena Sotillo; Robbie G Majzner
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.